ResearcherHeidelberg UniversityActive in the last 2 years
Eduard Ryschich
Matched on ORCID iD 0000-0002-2583-0495; OpenAlex author ID A5018615422. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 7
- Erratum to "Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas" [EJC 40 (2004) … Co-author DOI 10.1016/j.ejca.2026.116923↗
- Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Co-author DOI 10.18632/oncotarget.28527↗
- Collagen Organization Does Not Influence T-Cell Distribution in Stroma of Human Pancreatic Cancer. Last author DOI 10.3390/cancers13153648↗
- Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma. First author DOI 10.1038/bjc.2015.72↗
- Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Co-author DOI 10.18632/oncotarget.3171↗
- Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer. Last author DOI 10.1158/1078-0432.ccr-13-2972↗
- The role of the tumor endothelium in leukocyte recruitment in pancreatic cancer. Last author DOI 10.1016/j.surg.2012.05.027↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Thilo Hackert · 3 shared papers, 2015–2024 · strength 0.37
- Paper Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.28527↗
- Paper Collagen Organization Does Not Influence T-Cell Distribution in Stroma of Human Pancreatic Cancer. DOI 10.3390/cancers13153648↗
- Paper Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.3171↗
- J. Schmidt · 1 shared paper, 2026 · strength 0.36
- Alexandr V. Bazhin · 3 shared papers, 2015–2024 · strength 0.28
- Paper Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.28527↗
- Paper Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic ade… DOI 10.1038/bjc.2015.72↗
- Paper Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.3171↗
- Nathalia A. Giese · 3 shared papers, 2014–2024 · strength 0.28
- Paper Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.28527↗
- Paper Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer. DOI 10.1158/1078-0432.ccr-13-2972↗
- Paper Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.3171↗
- Nathalie Bauer · 2 shared papers, 2015–2024 · strength 0.23
- Paper Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.28527↗
- Paper Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.3171↗
- Pei Fan · 2 shared papers, 2015–2024 · strength 0.23
- Paper Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.28527↗
- Paper Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.3171↗
- Franco Fortunato · 2 shared papers, 2015–2024 · strength 0.23
- Paper Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.28527↗
- Paper Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.3171↗
- Li Liu · 2 shared papers, 2015–2024 · strength 0.23
- Paper Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.28527↗
- Paper Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.3171↗
- Yiyao Zhang · 2 shared papers, 2015–2024 · strength 0.23
- Paper Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.28527↗
- Paper Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.3171↗
- Oliver Strobel · 2 shared papers, 2015–2024 · strength 0.23
- Paper Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.28527↗
- Paper Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.3171↗
- Ingrid Herr · 2 shared papers, 2015–2024 · strength 0.23
- Paper Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.28527↗
- Paper Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.3171↗
- Eva-Maria Kamionka · 1 shared paper, 2021 · strength 0.14
- Jens Martin Werner · 2 shared papers, 2014–2015 · strength 0.10
- Dirk Jäger · 1 shared paper, 2015 · strength 0.05
- Werner Hartwig · 1 shared paper, 2015 · strength 0.05
- Svetlana Karakhanova · 1 shared paper, 2015 · strength 0.05
- Jan Schmidt · 1 shared paper, 2015 · strength 0.05
- Natalie Hartmann · 1 shared paper, 2014 · strength 0.05
- Rienk Offringa · 1 shared paper, 2014 · strength 0.05
- Isabel C. Poschke · 1 shared paper, 2014 · strength 0.05
- Jan Schmidt · 1 shared paper, 2012 · strength 0.04
- Jens Werner · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.